It’s Not Over Yet For Dexcom Inc (NASDAQ: DXCM)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

Dexcom Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Dexcom Inc is $53.47B. A total of 2.51 million shares were traded on the day, compared to an average of 3.07M shares.

In the most recent transaction, Brown Michael Jon sold 2,624 shares of DXCM for 140.04 per share on Mar 28 ’24. After the transaction, the EVP Chief Legal Officer now owns 68,682 company shares. In a previous transaction on Mar 25 ’24, Stern Sadie sold 4,137 shares at 140.00 per share. DXCM shares that EVP Chief Human Resources owns now total 76,304.

Among the insiders who sold shares, Dolan Matthew Vincent disposed of 4,203 shares on Mar 15 ’24 at a per-share price of $130.21. This resulted in the EVP Strategy & Corp Dev holding 44,367 shares of DXCM after the transaction. In another insider transaction, SAYER KEVIN R sold 81,007 shares at $133.36 per share on Mar 12 ’24. Company shares held by the President CEO and Chairman now total 333,526.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, DXCM has a high of $142.00 and a low of $74.75.

As of this writing, DXCM has an earnings estimate of $0.27 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.21. The company reported an EPS of $0.5 in the last quarter, which was 47.10% higher than expectations of $0.34.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.37, while its Total Shareholder’s Equity was $2.04B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.76.

Most Popular

Related Posts